Cough Reduction in IPF With Nalbuphine ER
Study sponsor: Trevi Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-04-24Actual
Enrollment · participants165Actual
Source updated2026-06-26Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.